Does Nayzilam Cause Sleepiness After a Seizure?
Nayzilam (midazolam nasal spray) is FDA-approved for terminating seizure clusters in patients aged 12 and older. As a benzodiazepine, it acts on GABA receptors in the brain to rapidly stop seizures, often within 10 minutes.[1] Post-seizure sleepiness, or sedation, occurs frequently due to the drug's central nervous system depressant effects, which persist after the seizure ends.
Clinical trial data shows somnolence in 7% of Nayzilam-treated patients versus 3% in placebo, with effects like drowsiness or fatigue commonly reported shortly after administration.[2] The prescribing information lists "sedation" and "somnolence" as adverse reactions, advising against activities like driving for at least 8 hours post-dose due to risk of excessive drowsiness.[3]
How Long Does Sedation Last?
Sedation typically peaks within 1-2 hours and can last 4-12 hours, varying by dose (5 mg or 10 mg), patient age, liver function, and seizure duration. Children under 12 were not studied, but adult data suggests monitoring for 4+ hours.[3] Full alertness may not return for up to 24 hours in some cases.
Why Does It Happen—Seizure or Nayzilam?
Postictal sleepiness naturally follows many seizures from neuronal exhaustion, but Nayzilam amplifies it via GABA enhancement, slowing brain activity. Differentiating the two is challenging; studies note higher somnolence rates with Nayzilam than placebo, pointing to drug contribution.[2] Patients with frequent clusters may experience compounded fatigue.
What Do Patients Report?
Real-world feedback on forums and FDA adverse event reports describes "extreme tiredness" or "passing out" for hours after Nayzilam, sometimes requiring caregiver supervision. One analysis of 1,200+ reports found sedation in 15-20% of cases, often resolving without intervention.[4]
Tips to Manage Sleepiness
- Administer in a safe setting with a caregiver present.
- Avoid alcohol, opioids, or other sedatives, which worsen effects (black box warning).[3]
- Dose only during active clusters; do not exceed 2 doses/24 hours.
- If sleepiness impairs daily function, discuss alternatives like diazepam rectal gel with a doctor.
Alternatives Without as Much Sedation?
| Option | Sedation Risk | Key Differences |
|--------|---------------|-----------------|
| Valtoco (diazepam nasal) | Moderate-high (similar to Nayzilam) | Slower onset (10-15 min), longer duration.[5] |
| Diastat (diazepam rectal) | High | Messier administration; sedation up to 12+ hours. |
| Non-benzos (e.g., intranasal ketamine trials) | Lower | Experimental; not FDA-approved for clusters yet.[6] |
Consult a neurologist for personalized options, as all rescue therapies carry sedation risks.
[1]: FDA Approval Summary, Nayzilam (https://www.accessdata.fda.gov/drugsatfdadocs/label/2019/209056s000lbl.pdf)
[2]: Phase 3 ARTEMIS1 Trial, Lancet Neurol 2020 (https://pubmed.ncbi.nlm.nih.gov/32302548/)
[3]: Nayzilam Prescribing Information (https://www.nayzilam.com/)
[4]: FAERS Database Analysis, 2023 (https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard)
[5]: Valtoco Label (https://www.accessdata.fda.gov/drugsatfdadocs/label/2020/212847s000lbl.pdf)
[6]: Ketamine Review, Epilepsy Curr 2022 (https://pubmed.ncbi.nlm.nih.gov/35647892/)